Trial Outcomes & Findings for Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury (NCT NCT01795079)

NCT ID: NCT01795079

Last Updated: 2021-03-17

Results Overview

Determine whether anodal transcranial direct current stimulation is effective in reducing pain in subjects with neuropathic pain due to burn injury, as measured by changes in the Brief Pain Inventory (BPI). Brief Pain Inventory (BPI) consist consists of a 9 part questionnaire. The questions include the severity of pain levels (worst, least, average, \& current), the impact of pain on daily functioning in different areas (mood, walking, relationships, sleep, normal work, \& general activity), current treatments and perceived effectiveness of current treatments. The VAS Pain scale is a simple 10- point scale (0 = ''no pain'', 10 = ''pain as bad as you can imagine'') measuring patients' worst pain and least pain, on average and at present time.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

34 participants

Primary outcome timeframe

2 weeks

Results posted on

2021-03-17

Participant Flow

Please note that 34 subjects consented to participated but 3 were screened out (after consent, there are additional tests to determine eligibility) and/or they dropped out before randomization (therefore, only 31 subjects were randomized).

Participant milestones

Participant milestones
Measure
Active tDCS
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Overall Study
STARTED
16
15
Overall Study
COMPLETED
13
12
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active tDCS
n=16 Participants
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=15 Participants
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Total
n=31 Participants
Total of all reporting groups
Age, Continuous
49 years
STANDARD_DEVIATION 14 • n=5 Participants
48 years
STANDARD_DEVIATION 14 • n=7 Participants
48.5 years
STANDARD_DEVIATION 14 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
7 Participants
n=7 Participants
16 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
15 Participants
n=5 Participants
14 Participants
n=7 Participants
29 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 weeks

Population: blinded assessment of scores at the primary endpoint (2 weeks)

Determine whether anodal transcranial direct current stimulation is effective in reducing pain in subjects with neuropathic pain due to burn injury, as measured by changes in the Brief Pain Inventory (BPI). Brief Pain Inventory (BPI) consist consists of a 9 part questionnaire. The questions include the severity of pain levels (worst, least, average, \& current), the impact of pain on daily functioning in different areas (mood, walking, relationships, sleep, normal work, \& general activity), current treatments and perceived effectiveness of current treatments. The VAS Pain scale is a simple 10- point scale (0 = ''no pain'', 10 = ''pain as bad as you can imagine'') measuring patients' worst pain and least pain, on average and at present time.

Outcome measures

Outcome measures
Measure
Active tDCS
n=13 Participants
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=12 Participants
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Change in Pain Scale
4.45 units on a scale
Standard Deviation 1.94
4.19 units on a scale
Standard Deviation 1.45

PRIMARY outcome

Timeframe: 2 weeks

Population: blinded assessment at primary endpoint (2 weeks)

Determine whether anodal transcranial direct current stimulation is effective in reducing itch severity/activity in subjects with neuropathic itching due to burn injury, as measured by changes in the Visual Analog Scale (VAS) .This is a 0 to 10 scale, where 0 indicates no intensity and a 10 indicates unbearable intensity of itching.

Outcome measures

Outcome measures
Measure
Active tDCS
n=13 Participants
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=12 Participants
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Change in Itch Severity/Activity Scale
3.65 units on a scale
Standard Deviation 2.91
1.83 units on a scale
Standard Deviation 1.76

SECONDARY outcome

Timeframe: 2 weeks

Population: blinded assessment of scores at the primary endpoint (2 weeks)

Determine whether anodal transcranial direct current stimulation is effective in decreasing severity of depression in subjects with neuropathic pain and itching due to burn injury, as measured by changes in the Beck Depression Inventory (BDI). The Beck Depression Inventory (BDI) contains 21 questions, each answer being scored on a scale value of 0 to 3 (total from 0-63). Higher total scores indicate more severe depressive symptoms.

Outcome measures

Outcome measures
Measure
Active tDCS
n=13 Participants
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=12 Participants
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Change in Depression Scale
9.1 score on a scale
Standard Deviation 7.1
9.2 score on a scale
Standard Deviation 7.8

SECONDARY outcome

Timeframe: 2 weeks

Population: blinded assessment of scores at the primary endpoint(2 weeks)

Determine whether anodal transcranial direct current stimulation is effective in decreasing post-traumatic stress symptoms in subjects with neuropathic pain and itching due to burn injury, as measured by changes in the Impact of Event Scale Revised (IES-R).This 22-item scale is designed to measure severity of PTS symptoms associated with a traumatic event. Subjects rate their level of distress associated with the event on a 0-4 scale (0 means not at all distressed, 4 means extremely distressed). The IES-R yields a total score (ranging from 0 to 88) where higher scores represent higher stress

Outcome measures

Outcome measures
Measure
Active tDCS
n=13 Participants
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=12 Participants
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Change in Post-Traumatic Stress Symptoms Scale
10.8 score on a scale
Standard Deviation 10.6
36.3 score on a scale
Standard Deviation 16.5

SECONDARY outcome

Timeframe: 2 weeks

Population: blinded assessment at the primary endpoint (2 weeks)

Determine whether anodal transcranial direct current stimulation is effective in decreasing severity of anxiety in subjects with neuropathic pain and itching due to burn injury, as measured by changes in the Visual Analog Scale (VAS).This is a self-evaluation scale that ranges from 0 to 10, where 0 means no anxiety and 10 means the worst anxiety ever.

Outcome measures

Outcome measures
Measure
Active tDCS
n=13 Participants
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=12 Participants
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Change in Anxiety Scale
3.25 units on a scale
Standard Deviation 3.62
2.92 units on a scale
Standard Deviation 3.37

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 weeks

Determine whether anodal transcranial direct current stimulation is effective in increasing quality of life in subjects with neuropathic pain and itching due to burn injury, as measured by changes in the Veterans RAND 36 Item Health Survey (VR-36). There are eight domains total including: bodily pain, role limitations due to physical problems, physical functioning, general health perception, vitality, social functioning, and role limitations due to mental health issues. Scores for each domain are from 0-100 with a higher score defining a more favorable health outcome.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 weeks

Determine whether anodal transcranial direct current stimulation is effective in increasing community integration functional outcomes in subjects with neuropathic pain and itching due to burn injury, as measured by changes in the Community Integration Questionnaire (CIQ). Total CIQ scores were used as the outcome measure. Contains 15 itms assessing community integrations across three domains (Home integration, social integration, productive activity) . The total score can range from 0 to 29 points (0 - minimal integration to 29 -maximal integration). A positive change indicates an improvement in integration.

Outcome measures

Outcome data not reported

Adverse Events

Active tDCS

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Sham tDCS

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Active tDCS
n=16 participants at risk
Subjects will undergo 20 minutes active tDCS. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Sham tDCS
n=15 participants at risk
Subjects will undergo 20 minutes of sham stimulation. Transcranial direct current stimulation (tDCS): Subjects will undergo 15 sessions of tDCS stimulation (either active or sham), 1x per day at 20 minutes per session.
Nervous system disorders
Hedache
12.5%
2/16 • Number of events 2 • Period of stimulation (3 weeks)
33.3%
5/15 • Number of events 9 • Period of stimulation (3 weeks)

Additional Information

Felipe Fregni

Spaulding Rehabilitation Hospital

Phone: 6179526158

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place